The first stop for professional medicines advice

Guidance

663 results

Applied filters

Managing the risk of confusion between injectable penicillin salts

4 October 2024Minimising the risk of confusion between injectable benzylpenicillin salt formulations may prevent harms.

Safe management of therapeutic drug monitoring

2 October 2024Organisations must ensure safe management systems are in place to support the management of drugs requiring therapeutic drug monitoring.

Managing medicines for people with sulfonamide allergy

2 October 2024Points to consider when prescribing and supplying medicines to people with sulfonamide allergy.

Managing risks associated with oxytocin infusions during labour

24 September 2024Safety strategies can minimise the risk of harms related to oxytocin infusion overdose and delayed therapy.

Dealing with OOS Microbiology Results in Pharmacy Aseptic Units (Part 2)

18 September 2024An SPS Quality Assurance (QA) bite size learning event on managing out of specification microbiological environmental monitoring results in aseptic units.

Using generic liposomal amphotericin B

13 September 2024A licensed generic liposomal amphotericin B (Tillomed) is available. Learn about key differences compared to AmBisome Liposomal amphotericin B (Gilead) brand.

Understanding the characteristics of Spikevax (JN.1) vaccine

10 September 2024An overview of the Spikevax (JN.1) vaccine and signposts to other useful resources

Understanding the characteristics of Comirnaty 30 (JN.1) vaccine

10 September 2024An overview of the Comirnaty 30 (JN.1) vaccine and signposts to other useful resources

Understanding the characteristics of Comirnaty 10 (JN.1) ready to use vaccine

10 September 2024An overview of the Comirnaty 10 (JN.1) ready to use vaccine and signposts to other useful resources

Understanding the characteristics of Comirnaty 3 (THREE) (JN.1) concentrate vaccine

10 September 2024An overview of the Comirnaty 3 (THREE) (JN.1) concentrate vaccine and signposts to other useful resources
admin